Literature DB >> 1848039

Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant.

C L Shields1, J A Shields, R C Eagle, P De Potter.   

Abstract

We studied the histopathologic findings after placement of an orbital hydroxyapatite implant in a patient. The implant was placed after enucleation for a choroidal melanoma and was removed four weeks later because histopathologic examination of the enucleated globe disclosed tumor invasion of the optic nerve that necessitated further orbital tissue removal. Our histopathologic findings confirm that there is significant ingrowth of fibrovascular tissue in these implants, even within weeks of implantation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848039     DOI: 10.1016/s0002-9394(14)72323-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  16 in total

1.  Correlation of histological findings with gadolinium enhanced MRI scans during healing of a PHEMA orbital implant in rabbits.

Authors:  C R Hicks; I T Morris; S Vijayasekaran; M J Fallon; J McAllister; A B Clayton; T V Chirila; G J Crawford; I J Constable
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

2.  [New ceramic materials for use in anophthalmia surgery].

Authors:  P Y Robert; J Rulfi; J P Adenis
Journal:  Ophthalmologe       Date:  2003-06-18       Impact factor: 1.059

3.  Comparison of experimental porous silicone implants and porous silicone implants.

Authors:  JunHyuk Son; Chang-sik Kim; JaeWook Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-28       Impact factor: 3.117

4.  Surgical coverage of exposed hydroxyapatite implant with retroauricular myoperiosteal graft.

Authors:  S L Liao; S C S Kao; J H S Tseng; L L-K Lin
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

5.  Cellular fibronectin and tenascin in an orbital nylon prosthesis removed because of infection caused by Staphylococcus aureus.

Authors:  T Päällysaho; K Tervo; T Kivelä; I Virtanen; A Tarkkanen; T Tervo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-02       Impact factor: 3.117

6.  Remove, rotate, and reimplant: a novel technique for the management of exposed porous anophthalmic implants in eviscerated patients.

Authors:  P Kaynak; G O Karabulut; C Ozturker; I Perente; B Gökyiǧit; A Demirok; O F Yilmaz
Journal:  Eye (Lond)       Date:  2014-02-07       Impact factor: 3.775

7.  [Porous orbital implants].

Authors:  B Cleres; H W Meyer-Rüsenberg
Journal:  Ophthalmologe       Date:  2014-06       Impact factor: 1.059

8.  Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases.

Authors:  C L Shields; J A Shields; P De Potter; A D Singh
Journal:  Trans Am Ophthalmol Soc       Date:  1993

9.  Three-phase bone scintigraphy of hydroxyapatite ocular implants.

Authors:  T Leitha; A Staudenherz; U Scholz
Journal:  Eur J Nucl Med       Date:  1995-04

10.  Hydroxyapatite spheres with controlled porosity for eye ball prosthesis: processing and characterization.

Authors:  E Rivera-Muñoz; J R Díaz; J Rogelio Rodríguez; W Brostow; V M Castaño
Journal:  J Mater Sci Mater Med       Date:  2001-04       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.